92P Selective elimination of CD133+ cancer stem cells using novel BET/HDAC inhibitor TW09 as therapy for pancreatic ductal adenocarcinoma (PDAC)
Autor: | Tiwary, K., Mader, S., Hauff, S., Valar, A., Ditrich, T., Zhang, X., Kleger, A., Seufferlein, T., Sanz, B., Jr, Siveke, J., Walter, K., Hermann, P.C. |
---|---|
Zdroj: | In Annals of Oncology October 2022 33 Supplement 8:S1411-S1411 |
Databáze: | ScienceDirect |
Externí odkaz: |